Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Synairgen Stock Soars 420% On Promise Of Inhaled COVID-19 Drug
Small Study Excites Investors
Jul 20 2020
•
By
Kevin Grogan
Synairgen Drug Shows Potential For Hospitalized COVID-19 Patients • Source: Shutterstock
More from COVID-19
More from Scrip